ST
SRT Therapeutics, Inc.
SEC filingBiotechnology · San Diego, CA
Amount raised$47.4Msold at filing
Total offering$47.5M$111K still open
Investors in the raise55count reported to the SEC
FiledAug 14, 2025first sale Apr 4, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Rolf BenirschkeDirector
Brian G. Feagan, M.D.Director
Ed PrunchunasDirector
Michael WalshDirector
Lauren OtsukiExecutive Officer, Director
Shierley WidjajaDirector
Executive officers, directors and promoters as listed on the Form D.